The Effect of Continuous Glucose Monitoring in Surgical Patients with Diabetes.

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

March 1, 2026

Conditions
Diabetes MellitusDysglycemiaPerioperative Complication
Interventions
DEVICE

Dexcom G7 Continuous Glucose Monitoring (CGM) System (G7)

A continuous glucose monitor which through a sensor in the skin registers glucose levels every 5 minutes. Glucose levels are shown by connecting the sensor to a mobile device or the Dexcom G7 Receiver where realtime alerts on deviating glucose levels will be sent.

Trial Locations (3)

2100

RECRUITING

Department of Anaesthesiology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen

2400

RECRUITING

Department of Anaesthesiology and Intensive Care, Bispebjerg Hospital, Copenhagen

4600

RECRUITING

Zealand University Hospital, Køge

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

Zealand University Hospital

OTHER

lead

Christian S. Meyhoff

OTHER